Retinal Degeneration Fund
2026-08-30retinaldegenerationfund.org
Overview
What they do
The Retinal Degeneration Fund (RD Fund) is focused on driving the future of retinal innovation through strategic investments that accelerate the development of novel therapeutics for inherited retinal diseases (IRDs) and dry age-related macular degeneration (dry AMD). It was designed to bridge the critical funding gap between discovery-stage research and drug development. The RD Fund operates as the venture arm of the Foundation Fighting Blindness, investing in companies developing life-changing therapies for patients with retinal diseases.
retinaldegenerationfund.org
What they look for
Invests strategically in companies developing novel therapeutics for inherited retinal diseases and dry age-related macular degeneration, targeting the funding gap between discovery research and drug development.
retinaldegenerationfund.org
Stage
Seed, Series A, Series B+
retinaldegenerationfund.org
Sectors
Healthcare
retinaldegenerationfund.org
Based
Raleigh, US
retinaldegenerationfund.org
Sources
2026-08-30retinaldegenerationfund.orgThe RD (Retinal Degeneration) Fund is a 501(c)(3) not-for-profit subsidiary of the Foundation…
2026-08-30retinaldegenerationfund.orgThe Retinal Degeneration Fund (RD Fund) is driving the future of retinal innovation through…
2026-08-30retinaldegenerationfund.orgRD Fund thesis is generally focused on therapeutic companies that range from nearing a pre-IND…
2026-08-30retinaldegenerationfund.orgAgnos Amber Bio Atsena Therapeutics Beacon Therapeutics Nacuity NVasc Opus Osanni Bio Perceive…
Portfolio, cheque size and the rest
The 19 companies they have backed that we can see, the cheque they write, and whether they are deploying right now.
Start free, no cardFree accounts see every record.